Global Testing Corporation (AYN) H2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 earnings summary
30 Oct, 2026Executive summary
FY2024 revenue rose 2.3% YoY to US$41.520m; profit for the year increased to US$5.147m from US$3.402m.
Higher orders, including new clients, supported growth; operating cash flow remained positive at US$9.254m.
Financial highlights
Revenue was US$41.520m versus US$40.586m in FY2023; cost of sales fell to US$32.099m from US$32.642m.
Gross profit increased 19% to US$9.421m; profit before tax was US$5.417m versus US$3.892m, and net profit was US$5.147m versus US$3.402m.
Other operating income rose to US$981k from US$657k, including US$733k interest income; income tax expense declined to US$270k from US$490k.
Cash and cash equivalents ended FY2024 at US$17.307m, compared with US$10.996m; financial asset investments were US$3.000m, down from US$9.016m.
Outlook and guidance
Tentative semiconductor-industry recovery signals persist, but geopolitical tensions and global economic headwinds are expected to sustain uncertainty into the coming year.
Focus remains on quality testing services, meeting customer demand, and strengthening supplier and client partnerships.
Energy-saving measures are planned for continued review in 2025 after cleanroom pressure adjustments in 2024 reduced energy loss and air-conditioning leakage.
Latest events from Global Testing Corporation
- Weaker semiconductor demand cut H1 net profit 61.3%; cautious conditions expected to persist.AYN
H1 2023 - Revenue and profit fell sharply, but operating cash flow stayed positive as 2024 outlook turned cautiously optimistic.AYN
H2 2023 - Lower orders cut 1H profit, while management expects a cautious 2H recovery.AYN
H1 2024 - Revenue rose 22% and net profit more than tripled amid trade uncertainty.AYN
H1 2025 - Revenue grew, but higher costs and taxes reduced FY2025 profit as uncertainty persisted.AYN
H2 2025 - Revenue grew 4%, but net profit fell 32% as costs and tax expense rose.AYN
H1 2026